−£2.85m
vs Jan 2025Active09939477Private limited companyManchester
GEN2 NEUROSCIENCE LTD
Significant control: Frederick John Livesey (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Gen2 Neuroscience Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Gen2 Neuroscience Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GEN2 NEUROSCIENCE LTD is an active private limited company (company number 09939477) incorporated on 7 January 2016, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 January 2026, showing net assets of −£2.85m and cash of £526, with 0 employees on average. Net assets fell 1% on the prior period (−£2.83m).
Peer position · net assets
By net assets it sits in the bottom quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Dr Frederick John Livesey
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 January 201610 yrs ago
- Next accounts due
- 31 October 2027in 371 days
- Confirmation statement due
- 21 January 2027in 88 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£526
−88%vs Jan 2025Not reported
0
−100%vs Jan 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2026 | −£2.85m | £526 | — | £2.85m | — | — | 0 |
| 31 January 2025 | −£2.83m | £4,390 | — | £2.84m | — | — | 1 |
Current ratio0Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-2,851,006 at 31 January 2026
- Current assets below creditors within one yearCurrent ratio 0.0
- Incorporated five or more years agoIncorporated 7 January 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 371 days
- Confirmation statement duein 88 days
- Accounts period endNet liabilities £2.85m · small accounts
- Accounts period endNet liabilities £2.83m · small accounts
- Incorporated
08
Similar companies in Manchester
- MEDICINES DISCOVERY CATAPULT LIMITEDMacclesfield · inc. Dec 2015
- BARINTHUS BIOTHERAPEUTICS (UK) LIMITEDAltrincham · inc. Jan 2016
- INFEX THERAPEUTICS LIMITEDMacclesfield · inc. Feb 2016
- OG1N LTDManchester · inc. Dec 2015
- NANOPTIMA LIMITEDNether Alderley · inc. Feb 2016
- BIVICTRIX LIMITEDMacclesfield · inc. Feb 2016
All companies incorporated on 7 January 2016 · in Jan 2016.
09
Reminders for GEN2 NEUROSCIENCE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.